AR104503A2 - Compuestos heterocíclicos de ácido borónico - Google Patents
Compuestos heterocíclicos de ácido borónicoInfo
- Publication number
- AR104503A2 AR104503A2 ARP160101246A ARP160101246A AR104503A2 AR 104503 A2 AR104503 A2 AR 104503A2 AR P160101246 A ARP160101246 A AR P160101246A AR P160101246 A ARP160101246 A AR P160101246A AR 104503 A2 AR104503 A2 AR 104503A2
- Authority
- AR
- Argentina
- Prior art keywords
- combination
- nateglinide
- repaglinide
- pharmaceutically acceptable
- boronic acid
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51956603P | 2003-11-12 | 2003-11-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR104503A2 true AR104503A2 (es) | 2017-07-26 |
Family
ID=37598221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160101246A AR104503A2 (es) | 2003-11-12 | 2016-05-02 | Compuestos heterocíclicos de ácido borónico |
Country Status (3)
| Country | Link |
|---|---|
| CN (3) | CN101074238A (zh) |
| AR (1) | AR104503A2 (zh) |
| ZA (1) | ZA200603803B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101074238A (zh) * | 2003-11-12 | 2007-11-21 | 芬诺密克斯公司 | 杂环硼酸化合物 |
| CN111533675B (zh) * | 2019-11-29 | 2021-09-28 | 杭州华东医药集团新药研究院有限公司 | 杂环硼酸化合物的杂质及其控制方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111785A0 (en) * | 1993-12-03 | 1995-01-24 | Ferring Bv | Dp-iv inhibitors and pharmaceutical compositions containing them |
| WO2003045228A2 (en) * | 2001-11-26 | 2003-06-05 | Trustees Of Tufts College | Methods for treating autoimmune disorders, and reagents related thereto |
| CN101074238A (zh) * | 2003-11-12 | 2007-11-21 | 芬诺密克斯公司 | 杂环硼酸化合物 |
-
2004
- 2004-11-12 CN CN 200710098129 patent/CN101074238A/zh active Pending
- 2004-11-12 CN CN200480037257.9A patent/CN1894261B/zh active Active
- 2004-11-12 CN CN 200810215690 patent/CN101362773B/zh active Active
-
2006
- 2006-05-12 ZA ZA200603803A patent/ZA200603803B/en unknown
-
2016
- 2016-05-02 AR ARP160101246A patent/AR104503A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1894261B (zh) | 2012-12-05 |
| ZA200603803B (en) | 2008-05-28 |
| CN1894261A (zh) | 2007-01-10 |
| CN101074238A (zh) | 2007-11-21 |
| CN101362773B (zh) | 2013-07-24 |
| CN101362773A (zh) | 2009-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2634716T3 (es) | Nuevos estabilizantes y moduladores del receptor GLP-1 | |
| ES2223981T3 (es) | Utilizacion de derivados detiazolidina opirrolidina de aminoacidos como agentes anti-hipergicemicos. | |
| AR084698A1 (es) | Composiciones de liberacion controlada con reducido efecto de alimentos, reducida interaccion entre farmaco y los alimentos | |
| HRP20191614T1 (hr) | Spojevi koji su suagonisti gip i glp-1 | |
| US8148412B2 (en) | Heteroaromatic glucokinase activators | |
| US7825139B2 (en) | Compounds and methods for selective inhibition of dipeptidyl peptidase-IV | |
| HRP20170478T1 (hr) | Farmaceutski pripravci albiglutida | |
| ES2819534T3 (es) | Derivados de pirimidina como moduladores del receptor GLP-1 | |
| ES2399052T3 (es) | Heteroaril-ureas y su uso como activadores de glucocinasa | |
| ES2713566T3 (es) | Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II | |
| KR101504769B1 (ko) | Ｄｐｐ-ⅳ 억제제의 고체 시트레이트 및 타르트레이트 염 | |
| AR104503A2 (es) | Compuestos heterocíclicos de ácido borónico | |
| US20070060547A1 (en) | Heterocyclic boronic acid compounds | |
| US7576121B2 (en) | Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV | |
| US8581001B2 (en) | Metformin-cysteine prodrug | |
| HRP20140091T4 (hr) | Davanje inhibitora dipeptidil peptidaze | |
| US20130253051A1 (en) | Controlled chemical release of hydrogen sulfide | |
| RU2434019C3 (ru) | Ацилированные glp-1 соединения | |
| ES2655396T3 (es) | Uso de metformina en combinación con un activador de glucoquinasa y composiciones que comprenden metformina y un activador de glucoquinasa | |
| CA2397294A1 (en) | Glyburide composition | |
| AR047776A1 (es) | Composiciones farmaceuticas glp - 1 | |
| RU2005127870A (ru) | Лекарственные средства для лечения сахарного диабета | |
| ECSP088353A (es) | Composiciones farmacéuticas que comprenden sustancias antidiabéticas combinadas para su uso en diabetes mellitus | |
| RU2012147449A (ru) | Способы использования диацереина в дополнительном лечении диабета | |
| Raiziss et al. | N1-heterocyclic sulfanilamide derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |